1. Home
  2. NRXP vs SHOT Comparison

NRXP vs SHOT Comparison

Compare NRXP & SHOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • SHOT
  • Stock Information
  • Founded
  • NRXP 2015
  • SHOT 2018
  • Country
  • NRXP United States
  • SHOT United States
  • Employees
  • NRXP N/A
  • SHOT N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • SHOT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRXP Health Care
  • SHOT Health Care
  • Exchange
  • NRXP Nasdaq
  • SHOT Nasdaq
  • Market Cap
  • NRXP 32.6M
  • SHOT 37.9M
  • IPO Year
  • NRXP N/A
  • SHOT 2020
  • Fundamental
  • Price
  • NRXP $2.24
  • SHOT $0.41
  • Analyst Decision
  • NRXP Strong Buy
  • SHOT
  • Analyst Count
  • NRXP 4
  • SHOT 0
  • Target Price
  • NRXP $28.50
  • SHOT N/A
  • AVG Volume (30 Days)
  • NRXP 184.4K
  • SHOT 1.5M
  • Earning Date
  • NRXP 05-15-2025
  • SHOT 05-23-2025
  • Dividend Yield
  • NRXP N/A
  • SHOT N/A
  • EPS Growth
  • NRXP N/A
  • SHOT N/A
  • EPS
  • NRXP N/A
  • SHOT N/A
  • Revenue
  • NRXP N/A
  • SHOT $701,967.00
  • Revenue This Year
  • NRXP N/A
  • SHOT N/A
  • Revenue Next Year
  • NRXP N/A
  • SHOT N/A
  • P/E Ratio
  • NRXP N/A
  • SHOT N/A
  • Revenue Growth
  • NRXP N/A
  • SHOT 246.36
  • 52 Week Low
  • NRXP $1.10
  • SHOT $0.34
  • 52 Week High
  • NRXP $6.01
  • SHOT $1.77
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 60.34
  • SHOT 43.69
  • Support Level
  • NRXP $1.97
  • SHOT $0.47
  • Resistance Level
  • NRXP $2.35
  • SHOT $0.52
  • Average True Range (ATR)
  • NRXP 0.12
  • SHOT 0.05
  • MACD
  • NRXP 0.03
  • SHOT -0.00
  • Stochastic Oscillator
  • NRXP 75.28
  • SHOT 23.20

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

Share on Social Networks: